Ichinose H, Nagatsu T
Institute for Comprehensive Medical Science, School of Medicine, Fujita Health University.
Nihon Rinsho. 1996 May;54(5):1453-9.
Hereditary progressive dystonia with marked diurnal fluctuation (HPD, Segawa's disease), also known as DOPA-responsive dystonia (DRD), was found to be caused by mutation of GTP cyclohydrolase I (GCH) gene. GCH activity in mononuclear blood cells was decreased to less than 20% of the normal values. The decrease in GCH activity causes the decrease in tetrahydrobiopterin (BH4) levels, resulting in decreased tyrosine hydroxylase (TH) activity and finally in decreased dopamine levels in the nigrostriatal dopamine neurons. In contrast, GCH activity in mononuclear blood cells in juvenile parkinsonism was normal. Recessive dystonia was shown to have a point mutation in TH gene. Thus, HPD (Segawa's disease) is distinct from recessive dystonia and juvenile parkinsonism. Patients with Parkinson's disease had decreased GCH activity in parallel with the decreases in TH activity and dopamine in the striatum, probably as the results of cell death.
伴有明显日波动的遗传性进行性肌张力障碍(HPD,又称Segawa病),也称为多巴反应性肌张力障碍(DRD),被发现是由GTP环化水解酶I(GCH)基因突变引起的。单核血细胞中的GCH活性降至正常水平的20%以下。GCH活性的降低导致四氢生物蝶呤(BH4)水平降低,进而导致酪氨酸羟化酶(TH)活性降低,最终导致黑质纹状体多巴胺神经元中的多巴胺水平降低。相比之下,青少年帕金森病患者单核血细胞中的GCH活性正常。隐性肌张力障碍被证明在TH基因中有一个点突变。因此,HPD(Segawa病)与隐性肌张力障碍和青少年帕金森病不同。帕金森病患者的GCH活性降低,同时纹状体中的TH活性和多巴胺水平也降低,这可能是细胞死亡的结果。